Monocyte chemoattractant protein-1: a dichotomous role in cardiac remodeling following acute myocardial infarction in man?
Weir
Robin A P
RA
Cardiology Department, Western Infirmary, Glasgow, Scotland, UK. robinweir75@hotmail.com
Murphy
Charles Aengus
CA
Petrie
Colin J
CJ
Martin
Thomas N
TN
Clements
Suzanne
S
Steedman
Tracey
T
Wagner
Galen S
GS
McMurray
John J V
JJ
Dargie
Henry J
HJ
D015415:Biomarkers / Q000097:blood; D018932:Chemokine CCL2 / Q000097:blood*; D015331:Cohort Studies; D003287:Contrast Media; D000077545:Eplerenone; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D020782:Matrix Metalloproteinases / Q000378:metabolism; D008875:Middle Aged; D000451:Mineralocorticoid Receptor Antagonists / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000097:blood* / Q000188:drug therapy / Q000201:enzymology / Q000503:physiopathology*; D013148:Spironolactone / Q000031:analogs & derivatives / Q000627:therapeutic use; D013997:Time Factors; D016277:Ventricular Function, Left / Q000502:physiology; D020257:Ventricular Remodeling / Q000502:physiology*
D015415:Biomarkers; D018932:Chemokine CCL2; D003287:Contrast Media; D000451:Mineralocorticoid Receptor Antagonists; D013148:Spironolactone; D000077545:Eplerenone; D020782:Matrix Metalloproteinases